Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity - Mines Paris Accéder directement au contenu
Article Dans Une Revue Toxicology in Vitro Année : 2017

Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity

Résumé

Cerium oxides (CeO2) nanoparticles, also referred to as nanoceria, are extensively used with a wide range of applications. However, their impact on human health and on the environment is not fully elucidated. The aim of this study was to investigate the influence of the CeO2 nanoparticles morphology on their in vitro toxicity. CeO2 nanoparticles of similar chemical composition and crystallinity were synthesized, only the shape varied (rods or octahedrons/cubes). Macrophages from the RAW264.7 cell line were exposed to these different samples and the toxicity was evaluated in terms of lactate dehydrogenase (LDH) release, Tumor Necrosis Factor alpha (TNF-α) production and reactive oxygen species (ROS) generation. Results showed no ROS production, whatever the nanoparticle shape. The LDH release and the TNF-α production were significantly and dose-dependently enhanced by rod-like nanoparticles, whereas they did not vary with cubic/octahedral nanoparticles. In conclusion, a strong impact of CeO2 nanoparticle morphology on their in vitro toxicity was clearly demonstrated, underscoring that nanoceria shape should be carefully taken in consideration, especially in a “safer by design” context.
Fichier principal
Vignette du fichier
2016_HAL_Forest_TIV.pdf (763.79 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-01421912 , version 1 (09-10-2018)

Identifiants

Citer

Valérie Forest, Lara Leclerc, Jean-François Hochepied, Adeline Trouvé, Gwendoline Sarry, et al.. Impact of cerium oxide nanoparticles shape on their in vitro cellular toxicity. Toxicology in Vitro, 2017, 38, pp.136-141. ⟨10.1016/j.tiv.2016.09.022⟩. ⟨hal-01421912⟩
237 Consultations
1022 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More